NILK-2301

· Light Chain Bioscience / Novimmune SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NILK-2301, covering 2024-10-29 to 2024-10-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer [Phase 1]

See pricing